Product
AMG 598
1 clinical trial
1 indication
Indication
ObesityClinical trial
A Phase 1b, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 598 in Subjects With ObesityStatus: Completed, Estimated PCD: 2019-12-16